ArticleFrontiers in pharmacology2025

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report.

Jianxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.